CA2203083A1 - Gene et adnc intervenant dans la maladie d'alzheimer - Google Patents

Gene et adnc intervenant dans la maladie d'alzheimer

Info

Publication number
CA2203083A1
CA2203083A1 CA 2203083 CA2203083A CA2203083A1 CA 2203083 A1 CA2203083 A1 CA 2203083A1 CA 2203083 CA2203083 CA 2203083 CA 2203083 A CA2203083 A CA 2203083A CA 2203083 A1 CA2203083 A1 CA 2203083A1
Authority
CA
Canada
Prior art keywords
disease
alzheimer
gene
protein
inositol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2203083
Other languages
English (en)
Inventor
Gail Ouellette
Denis Gauvreau
Isabel Fortier
Yves Robitaille
Mario Filion
Magid Belouchi
Original Assignee
ALGENE BIOTECHNOLOGIES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALGENE BIOTECHNOLOGIES filed Critical ALGENE BIOTECHNOLOGIES
Priority to CA 2203083 priority Critical patent/CA2203083A1/fr
Publication of CA2203083A1 publication Critical patent/CA2203083A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA 2203083 1997-04-18 1997-04-18 Gene et adnc intervenant dans la maladie d'alzheimer Abandoned CA2203083A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2203083 CA2203083A1 (fr) 1997-04-18 1997-04-18 Gene et adnc intervenant dans la maladie d'alzheimer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2203083 CA2203083A1 (fr) 1997-04-18 1997-04-18 Gene et adnc intervenant dans la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
CA2203083A1 true CA2203083A1 (fr) 1998-10-18

Family

ID=4160470

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2203083 Abandoned CA2203083A1 (fr) 1997-04-18 1997-04-18 Gene et adnc intervenant dans la maladie d'alzheimer

Country Status (1)

Country Link
CA (1) CA2203083A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064730A1 (fr) * 2000-03-02 2001-09-07 Biowindow Gene Development Inc. Shanghai Nouveau polypeptide, 5-phosphatase humaine 18, et polynucleotide codant pour ce polypeptide
EP1404863A1 (fr) * 2001-06-05 2004-04-07 Exelixis, Inc. Phosphatidylinositol biphosphates (pib) en tant que modificateurs de la voie metabolique du gene p53 et procedes d'utilisation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064730A1 (fr) * 2000-03-02 2001-09-07 Biowindow Gene Development Inc. Shanghai Nouveau polypeptide, 5-phosphatase humaine 18, et polynucleotide codant pour ce polypeptide
EP1404863A1 (fr) * 2001-06-05 2004-04-07 Exelixis, Inc. Phosphatidylinositol biphosphates (pib) en tant que modificateurs de la voie metabolique du gene p53 et procedes d'utilisation
EP1404863A4 (fr) * 2001-06-05 2005-05-11 Exelixis Inc Phosphatidylinositol biphosphates (pib) en tant que modificateurs de la voie metabolique du gene p53 et procedes d'utilisation

Similar Documents

Publication Publication Date Title
Krüger et al. Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype
US20180010190A1 (en) Genetic variant of the annexin a5 gene
US20040132021A1 (en) Osteolevin gene polymorphisms
AU2006225995B2 (en) Human autism susceptibility gene encoding a transmembrane protein and uses thereof
EP1377678A2 (fr) Application diagnostique et therapeutique d'une proteine membranaire integrale associee aux caveolae a la maladie d'alzheimer et aux troubles neurodegeneratifs associes
WO2003076658A2 (fr) Gene de predisposition a la maladie de parkinson idiopathique a apparition tardive
CA2203083A1 (fr) Gene et adnc intervenant dans la maladie d'alzheimer
US20060141462A1 (en) Human type II diabetes gene-slit-3 located on chromosome 5q35
EP1476553A2 (fr) Gene pour le traitement d'une la maladie occlusive arterielle peripherique
CA2203084A1 (fr) Voie des phosphates d'inositol et leur role dans la maladie d'alzheimer
EP0811695A2 (fr) Gènes S182(PS-1) mutés
US6083694A (en) Method for elucidation and detection of polymorphisms, splice variants, and proximal coding mutations using intronic sequences of the alzheimer's S182 gene
CA2203070A1 (fr) Gene du chromosome 6 et produits genetiques associes a la maladie d'alzheimer
CA2203071A1 (fr) Gene du chromosome 10 et produits genetiques associes a la maladie d'alzheimer
WO1996032502A1 (fr) Reactif specifique des polymorphismes de l'apolipoproteine-j et ses utilisations
Hardy et al. Genetic variability and Alzheimer’s disease
US20150031569A1 (en) Mutations of the GPR179 Gene in Congenital Stationary Night Blindness
CA2203069A1 (fr) Gene du chromosome 12 et produits genetiques associes a la maladie d'alzheimer
CA2203072A1 (fr) Marqueurs chromosomiques associes a la maladie d'alzheimer
CA2203068A1 (fr) Gene du chromosome 1p et produits genetiques associes a la maladie d'alzheimer
US20050130165A1 (en) Polymorphism of soati useful for identifying risk of developing alzheimer's disease
CA2203085A1 (fr) 5-phosphatase de type ii et son role dans la maladie d'alzheimer
EP0833947A1 (fr) Variants du gene preseniline 2
US20020182669A1 (en) GPI-anchored small leucine-rich proteoglycan gene NYX
Class et al. Patent application title: FAM26C POLYMORPHISMS AND USE THEREOF FOR THE DIAGNOSTIC AND TREATMENT OF LATE ONSET ALZHEIMER'S DISEASE Inventors: Philippe Marambaud (Astoria, NY, US) Fabien Campagne (Astoria, NY, US)

Legal Events

Date Code Title Description
FZDE Dead